Is atrial fibrillation ablation a "slam dunk" for athletes? When would a clinician favor pharmacotherapy?

In this episode, Michael S. Emery, MD, MS, FACC debates Mark S Link, MD on Atrial Fibrillation Management in Athletes, moderated by Alison L. Bailey, MD FACC.

References

1. Mandsager KT, Phelan DM, Diab M. Outcomes of Pulmonary Vein Isolation in Athletes. JACC Clin Electrophysiol 2020;6:1265-1274.
2. Kirchhof P, Camm JA, Goette A, et al., for the EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 2020; 383:1305-1316.
3. Poole JE, Bahnson TD, Monahan KH, et al., on behalf of the CABANA Investigators and ECG Rhythm Core Lab. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. J Am Coll Cardiol 2020;75:3105-18
4. Saglietto A, De Ponti R, Di Biase L. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta-analysis. J Cardiovasc Electrophysiol 2020;31:1040-1047.

Clinical Topics: Arrhythmias and Clinical EP, Sports and Exercise Cardiology, Atrial Fibrillation/Supraventricular Arrhythmias

Keywords: ACCELLite, Atrial Fibrillation, Sports

< Back to Listings